NEWTOWN, Pa.--(BUSINESS WIRE)--BioClinica®, Inc. (NASDAQ: BIOC), a global provider of clinical trial management solutions, is quickly becoming the eClinical provider of choice for European pharmaceutical, medical device, biotechnology and contract research organizations (CROs). BioClinica’s combination of nimble programing, scalability, ease of use, and high value are winning the attention of European companies tired of outdated, slow-moving, cumbersome eClinical systems.
